A medical device industry executive with broad operational experience. Quinton has served in executive roles for over 25 years and has more than 35 years of medical device experience. While leading West Surry he also served as Senior Vice President of Technical Operations R&D/RA/QA/Operations for Velano Vascular for the 6 years leading up to the acquisition by Becton-Dickinson. Prior to founding West Surry Strategies LLC, he was the Global VP of Operations Technology and R&D at Smiths Medical. At Smiths he led the effort to increase OI from 18% to 25% and increased new product from 3% to 14% of sales. Prior to joining Smiths in 2003, Quinton was the Sr. VP Technology Development/RA/QA with Genzyme Biosurgical. He joined Genzyme when they acquired the privately held medical device manufacturer Deknatel Snowden-Pencer where he was the Executive VP of Technology Development. Quinton had a leadership role in taking this firm private during a management buyout from Pfizer Hospital Products. During his tenure with the Pfizer Division, Deknatel, he served as a Project Engineer, Director, and VP of Product Development as well as the Group VP of Blood Recovery. Quinton started his medical device career at NMC and progressed to BD. He has more than 30 patents and developed more than 100 cleared devices.Quinton has a BSME from Fairleigh Dickinson University. He lives in Waterville Valley NH.

Quinton Farrar is a highly experienced medical device industry executive with over 25 years of experience. He has held executive roles in various companies, including West Surry and Velano Vascular. Quinton has also served as the Senior Vice President of Technical Operations R&D/RA/QA/Operations for Velano Vascular and the Global VP of Operations Technology and R&D at Smiths Medical. He has a strong background in sales and has led the growth of new products and new product. Quinton has a BSME from Fairleigh Dickinson University and is currently based in the United States.